Skip to main content
Figure 3 | Molecular Cancer

Figure 3

From: In non-transplant patients with multiple myeloma, the pre-treatment level of clonotypic cells predicts event-free survival

Figure 3

Kaplan Meier Curves of BMPC or Matched VDJ% to EFS. The median BMPC percentage dichotomized the group but did not indicate significantly different EFSs (A). The same patient cohort, categorized by VDJ% above and below the median, significantly correlates with EFS (B). If only non-transplant patient samples were included, the EFS compared to the BMPC remains insignificant (C) and the EFS compared to VDJ% remains significant (D).

Back to article page

Molecular Cancer

ISSN: 1476-4598